CO4920218A1 - Agentes terapeuticos con base en idoxifeno, utiles en el tratamiento de la osteoporosis - Google Patents

Agentes terapeuticos con base en idoxifeno, utiles en el tratamiento de la osteoporosis

Info

Publication number
CO4920218A1
CO4920218A1 CO97051287A CO97051287A CO4920218A1 CO 4920218 A1 CO4920218 A1 CO 4920218A1 CO 97051287 A CO97051287 A CO 97051287A CO 97051287 A CO97051287 A CO 97051287A CO 4920218 A1 CO4920218 A1 CO 4920218A1
Authority
CO
Colombia
Prior art keywords
idoxifeno
osteoporosis
useful
treatment
therapeutic agents
Prior art date
Application number
CO97051287A
Other languages
English (en)
Spanish (es)
Inventor
Jeremy N Bradbeer
Maxine Gowen
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of CO4920218A1 publication Critical patent/CO4920218A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Pyridine Compounds (AREA)
CO97051287A 1996-09-06 1997-09-04 Agentes terapeuticos con base en idoxifeno, utiles en el tratamiento de la osteoporosis CO4920218A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2543996P 1996-09-06 1996-09-06
US5066697P 1997-06-24 1997-06-24

Publications (1)

Publication Number Publication Date
CO4920218A1 true CO4920218A1 (es) 2000-05-29

Family

ID=26699738

Family Applications (2)

Application Number Title Priority Date Filing Date
CO97051289A CO5070658A1 (es) 1996-09-06 1997-09-04 Agentes terapeuticos utiles para el tratamiento y prevencion de enfermedades cardio vasculares en mujeres posmenopausi- cas
CO97051287A CO4920218A1 (es) 1996-09-06 1997-09-04 Agentes terapeuticos con base en idoxifeno, utiles en el tratamiento de la osteoporosis

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CO97051289A CO5070658A1 (es) 1996-09-06 1997-09-04 Agentes terapeuticos utiles para el tratamiento y prevencion de enfermedades cardio vasculares en mujeres posmenopausi- cas

Country Status (16)

Country Link
EP (2) EP0927029A4 (zh)
JP (2) JP2002515046A (zh)
KR (2) KR20000068473A (zh)
CN (2) CN1236313A (zh)
AR (1) AR008155A1 (zh)
AU (2) AU4409797A (zh)
BR (2) BR9711676A (zh)
CA (2) CA2264943A1 (zh)
CO (2) CO5070658A1 (zh)
CZ (1) CZ76699A3 (zh)
IL (1) IL128645A0 (zh)
NO (2) NO991097D0 (zh)
PL (2) PL332278A1 (zh)
TR (2) TR199900506T2 (zh)
TW (1) TW411273B (zh)
WO (2) WO1998009619A1 (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5749998A (en) * 1997-02-11 1998-08-26 Novo Nordisk A/S Methods for treatment or prophylaxis of menopausal symptoms
GB9827121D0 (en) * 1998-12-09 1999-02-03 Orion Corp Agent for lowering endothelin levels
DE19905961A1 (de) * 1999-02-12 2000-08-17 Stefan Neubauer Verwendung von Östrogenen zur Behandlung der Herzinsuffizienz
US6528681B2 (en) * 2000-04-05 2003-03-04 Bristol-Meyers Squibb Pharma Company Halogenated triphenylethylene derivatives as selective estrogen receptor modulators
TWI303990B (en) 2000-10-17 2008-12-11 Pfizer Prod Inc New use of estrogen agonists/antagonists for improving vascular health

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2196003A (en) * 1986-09-11 1988-04-20 Nat Res Dev Iodo-and bromo-tamoxifen derivatives
ES2112994T3 (es) * 1992-09-15 1998-04-16 Merrell Pharma Inc Analogos de clomifeno no metabolizables utilizados en el tratamiento de tumores resistentes al tamoxifeno.
US6197789B1 (en) * 1995-06-07 2001-03-06 Neorx Corporation Prevention and treatment of cardiovascular pathologies with tamoxifen analogues
US5681835A (en) * 1994-04-25 1997-10-28 Glaxo Wellcome Inc. Non-steroidal ligands for the estrogen receptor
US5604248A (en) * 1994-05-05 1997-02-18 Eli Lilly And Company Method for minimizing the uterotrophic effect of tamoxifen and tamoxifen analogs
US5470883A (en) * 1994-05-23 1995-11-28 Stromberg; Brent V. Method of treating peripheral vasoconstriction with tamoxifen citrate
HN1996000101A (es) * 1996-02-28 1997-06-26 Inc Pfizer Terapia combinada para la osteoporosis
US6069175A (en) * 1996-11-15 2000-05-30 Pfizer Inc. Estrogen agonist/antagonists treatment of atherosclerosis

Also Published As

Publication number Publication date
TW411273B (en) 2000-11-11
WO1998009619A1 (en) 1998-03-12
AR008155A1 (es) 1999-12-09
PL332278A1 (en) 1999-08-30
JP2002515047A (ja) 2002-05-21
TR199900504T2 (xx) 1999-06-21
WO1998009519A1 (en) 1998-03-12
KR20000068473A (ko) 2000-11-25
JP2002515046A (ja) 2002-05-21
CO5070658A1 (es) 2001-08-28
NO991097L (no) 1999-03-05
CN1236299A (zh) 1999-11-24
NO991097D0 (no) 1999-03-05
AU4247397A (en) 1998-03-26
NO991096D0 (no) 1999-03-05
BR9711676A (pt) 1999-08-24
EP0927029A4 (en) 2001-06-13
NO991096L (no) 1999-03-05
CA2264943A1 (en) 1998-03-12
EP0929216A4 (en) 2001-04-04
CN1236313A (zh) 1999-11-24
EP0927029A1 (en) 1999-07-07
EP0929216A1 (en) 1999-07-21
CZ76699A3 (cs) 1999-08-11
CA2264775A1 (en) 1998-03-12
IL128645A0 (en) 2000-01-31
PL332038A1 (en) 1999-08-16
AU4409797A (en) 1998-03-26
BR9711681A (pt) 1999-08-24
KR20000068472A (ko) 2000-11-25
TR199900506T2 (xx) 1999-07-21

Similar Documents

Publication Publication Date Title
ES2067937T3 (es) (+)-alfa-(2,3-dimetoxifenil)-1-(2-(4-fluorofenil)etil)-4-piperidinametanol.
AR013742A1 (es) Metodo para el tratamiento de la hipercolesterolemia con polidialilamina no substituida
RU94044436A (ru) Способы подавления атрофии кожи и влагалища
EA200300036A1 (ru) Комбинации ингибиторов дипептидилпептидазы iv и других антидиабетических агентов для лечения сахарного диабета
BR0212252A (pt) Métodos para reduzir a hipertensão e a insuficiência cardìaca em um mamìfero
ES2164916T3 (es) Tratamiento de la esclerosis multiple.
FI971420A (fi) Menetelmä diabetes mellituksen hoitamiseksi KGF:ää käyttämällä
ES2105525T3 (es) 2-fenil-3-aroilbenzotiofenos antiestrogenicos como agentes hipoglicemicos.
RU94044490A (ru) Применение 2-фенил-3-ароилбензотиофенов для подавления дефектного восстановления ткани
MX9701325A (es) Metodos para inhibir la mucositis ulcerativa.
ES2157960T3 (es) Procedimiento para aumentar la libido en mujeres postmenopausicas.
EA199800717A1 (ru) Способ лечения заболеваний млекопитающих и цвиттерионная композиция
CO4920218A1 (es) Agentes terapeuticos con base en idoxifeno, utiles en el tratamiento de la osteoporosis
ES2185942T3 (es) Uso de la l-lisina en el tratamiento de la perdida del cabello.
SE9600120D0 (sv) Novel medical use
FI934680A (fi) Arylmorfolin, framstaellning och anvaending
CO4700479A1 (es) Agentes antifungicos de peptidos ciclicos
EA199800015A1 (ru) Способ ингибирования меланомы
EA199700136A1 (ru) Способы ингибирования экзогенных эстрогенов
DK0840607T3 (da) Ny medicinsk anvendelse
SE9504267D0 (sv) New therapeutic use
DE69729201T2 (de) Sulfonfluoride zur behandlung von der alzheimerischen krankheit
DE69813681D1 (de) Neue triazole als therapeutische mittel gegen pilzinfektionen
RU94044487A (ru) Применение 2-фенил-3-ароилбензотиофенов для лечения мужского бесплодия
MX9701332A (es) Metodos para curar y reparar fracturas oseas.